TrialEuropean urology oncology2025

Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).

Daniel Sentana-Lledo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.